🇺🇸 Bilastin in United States

16 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Agitation — 2 reports (12.5%)
  2. Anxiety — 2 reports (12.5%)
  3. Aspartate Aminotransferase Increased — 2 reports (12.5%)
  4. Fatigue — 2 reports (12.5%)
  5. Hypoaesthesia — 2 reports (12.5%)
  6. Pyrexia — 2 reports (12.5%)
  7. Alanine Aminotransferase Increased — 1 report (6.25%)
  8. Anaemia — 1 report (6.25%)
  9. Aphonia — 1 report (6.25%)
  10. Arrhythmia — 1 report (6.25%)

Source database →

Bilastin in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Other approved in United States

Frequently asked questions

Is Bilastin approved in United States?

Bilastin does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Bilastin in United States?

Charite University, Berlin, Germany is the originator. The local marketing authorisation holder may differ — check the official source linked above.